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Objetives: Farnesol is a naturally-occurring sesquiterpene that was originally isolated from essential oils found in 
many plants has been described to have antimicrobial potential against several bacteria, including S. epidermidis. 
However, farnesol mechanism of action is not yet fully understood and some contradictory findings have been 
reported. We recently described that while farnesol was not efficient at killing biofilm bacteria, a strong 
reduction on biofilm biomass was detected, and we hypothesize that farnesol could be inducing biofilm 
detachment. Here, we address this hypothesis.  
Methods: To test our hypothesis we used 36 representative clinical strains of S. epidermidis from different parts 
of the world and characterized them in terms of genetic variability, biofilm formation and on the effect of 
farnesol on biofilm physiology and gene expression.  
Results: Farnesol had no bactericidal effect on stationary phase populations equal or above 108 CFU/mL. In 
exponential phase planktonic bacteria, farnesol showed a bacteriostatic effect after cell density reached 108 
CFU/mL. In any of the growth phases studied, farnesol was effective in killing above 90% of bacteria in 4 h 
when cell density was 107 CFU/mL or below. 
Confocal microscopy and flow citometry analysis confirmed that in biofilms bacteria were not killed by farnesol 
but nevertheless cell wall integrity was affected. Gene expression studies revealed differential responses to 
farnesol, depending on the bacterial strain tested. Farnesol cell detachement from biofilms was also strain-
dependent.
Conclusions: We found that while farnesol cannot kill high density bacterial communities, such as biofilms, it 
was nevertheless able to induce biofilm detachment in 50% of the strains that formed biofilm. 
Keywords biofilms; antimicrobial resistant; cell detachment; gene expression; confocal microscopy 
II International Conference on Antimicrobial Research - ICAR2012 
              Lisbon (Portugal) 21-23 November 2012
207
Fast-forwarding anti-biofilm drug discovery by enhancement of chemical 
screenings from natural products 
A. Fallarero1,, M. Skogman1, J. Kujala1 and P. Vuorela1
1Drug Discovery and Pharmaceutical Biology, Pharmaceutical Sciences, Department of Biosciences, Åbo Akademi 
University, Artillerigatan 6A, 3rd floor, FIN-20520, Biocity, Turku, Finland 
Bacteria can exist in two different states: as single cells (the so-called suspensions) or as communities of cells 
(known as biofilms). Intensive research has been conducted aimed to understand the processes occuring in 
biofilms and the factors responsible for their extremely high resistance to biocides. However, no much success 
has been reached in finding antibiotics that can effectively and selectively kill biofilm bateria. A major part of the 
problem still resides on the antimicrobial screening assays at hand, which are traditionally based on suspensions 
and not all fully suited to anti-biofilm screens. Thus, during the past years, our laboratory has embraced the 
development of phenotypic assays that can be used for the identification of anti-biofilm compounds.  
We have established a two-phased platform consisting of three assays aimed at identifying inhibitors of 
Staphylococcus aureus biofilms acting on the viable biofilm core and/or the extracellular polymeric substance 
(EPS) in which biofilms are encased. In a first phase, compounds are screened for effects on biofilm viability 
with a one-step fluorescence assay measuring resazurin reduction. As this method is non-invasive, compounds 
are further screened sequentially in the same plate for effects on biofilm biomass, using crystal violet staining. In 
the second phase, hits are screened for 
effects on the EPS, by staining with a 
wheat germ agglutinin-Alexa Fluor 488 
fluorescent conjugate. By measuring 
these three endpoints (viability, biomass 
and EPS production) a more accurate 
picture of the chemotherapeutic effect of 
the hits can be achieved. For instance, 
two known antibiotics (penicillin and 
ciprofloxacin) have been shown to cause 
a reduction on the viability and biomass 
that is accompanied by an increase or not 
changed levels of the EPS (Figure 1).
Thus, the combination of these assays 
have revealed that, on the long-term, 
exposure to these antibiotics can lead to 
faster biofilm recolonization1.
Further on, screening campaigns involving around 2000 naturally-derived pure compounds and 100 bacterial 
extracts from strains isolated from Artic environments, have been carried out. One bacterial extract and four 
compounds of natural origin have been identified with ability to destroy previously formed biofilms. The effects 
of the pure compounds on suspended bacteria have been also measured to assess their likelihood to induce 
bacterial resistance. Finally, using the PCA-based navigation tool ChemGPS-NP2, 3, the chemical space occupied 
by the active compounds has been defined, thus giving the foundations for future anti-biofilm in silico screening 
of chemical libraries. The benefits of this screening strategy are that: i) it allows the identification of “true” hits; 
ii) it is time-effective and statistically robust; iii) it can be applied throughout the early discovery process from 
hit identification to lead characterization.  
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Figure 1. Effects of two model antibiotics on the EPS production, 
biomass and viability of 18hrs-formed biofilms, as measured using 
the anti-biofilm platform described here.  
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